Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Pharmaceutical Journal
Aprianto, Yakobus
Unknown Affiliation
Dentistry Medicine & Pharmacology Nursing Public Health Other

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Dampak Harmonisasi Regulasi Farmasi terhadap Akses Obat dan Keamanan Pasien Aminudin; Azzahra, Naila; Putri, Tiara Ananda; Aprianto, Yakobus
Pharmaceutical Journal Vol. 1 No. 2 (2025): August Editions
Publisher : Program Studi Farmasi Sekolah Tinggi Ilmu Kesehatan Sambas

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

This study is a literature review that aims to comprehensively examine health and drug regulation from three perspectives: the implementation of Real-World Evidence (RWE), the application of Good Regulatory Practices for Medicines (CROB), and a comparison of health regulations across countries. Using a literature review method, the findings indicate that Indonesia faces significant challenges in integrating RWE into its drug approval system, particularly due to limited data infrastructure, regulatory gaps, and data ethics issues. On the other hand, the CROB guidelines issued by the National Agency of Drug and Food Control (BPOM) represent a crucial effort to build a regulatory system that is transparent, accountable, and evidence-based. Furthermore, cross-country comparisons affirm that strict regulations positively impact the quality of healthcare services, enhancing patient safety and the competence of medical personnel. This study concludes that adaptive, integrated, and consistent regulation is essential to ensure the quality of medicines and healthcare services, and that harmonizing policies across sectors and countries is necessary to address global health challenges.
Co-Authors AMINUDIN Azzahra, Naila Putri, Tiara Ananda